- Home
- MPV vs RAPT Comparison
MPV vs RAPT Comparison
Compare MPV & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPV
- RAPT
- Stock Information
- Founded
- MPV 1988
- RAPT 2015
- Country
- MPV United States
- RAPT United States
- Employees
- MPV N/A
- RAPT N/A
- Industry
- MPV Finance Companies
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- MPV Finance
- RAPT Health Care
- Exchange
- MPV Nasdaq
- RAPT Nasdaq
- Market Cap
- MPV 201.1M
- RAPT 194.2M
- IPO Year
- MPV N/A
- RAPT 2019
- Fundamental
- Price
- MPV $19.56
- RAPT $13.28
- Analyst Decision
- MPV
- RAPT Buy
- Analyst Count
- MPV 0
- RAPT 5
- Target Price
- MPV N/A
- RAPT $33.60
- AVG Volume (30 Days)
- MPV 25.2K
- RAPT 117.5K
- Earning Date
- MPV 01-01-0001
- RAPT 08-07-2025
- Dividend Yield
- MPV 8.71%
- RAPT N/A
- EPS Growth
- MPV N/A
- RAPT N/A
- EPS
- MPV 1.71
- RAPT N/A
- Revenue
- MPV N/A
- RAPT N/A
- Revenue This Year
- MPV N/A
- RAPT N/A
- Revenue Next Year
- MPV N/A
- RAPT N/A
- P/E Ratio
- MPV $9.35
- RAPT N/A
- Revenue Growth
- MPV N/A
- RAPT N/A
- 52 Week Low
- MPV $11.18
- RAPT $5.67
- 52 Week High
- MPV $16.42
- RAPT $26.56
- Technical
- Relative Strength Index (RSI)
- MPV 50.07
- RAPT 64.67
- Support Level
- MPV $19.43
- RAPT $11.19
- Resistance Level
- MPV $20.46
- RAPT $13.66
- Average True Range (ATR)
- MPV 0.49
- RAPT 0.82
- MACD
- MPV -0.04
- RAPT 0.18
- Stochastic Oscillator
- MPV 36.16
- RAPT 89.44
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.